AstraZeneca completes EsoBiotec acquisition for up to $1 billion
AstraZeneca PLC on Tuesday said it has completed its acquisition of Belgian biotechnology firm EsoBiotec SA, bolstering its cell therapy capabilities with a platform that...
Tue, 20/05/2025 - 08:55